MDCG 2020-16 Guidance on Classification Rules for IVDR

MDCG 2020-16 Guidance on Classification Rules for in vitro Diagnostic Medical Devices under Regulation (EU) 2017/746

Article 47 of the IVDR EU 2017/746 defines four new risk classes (A, B, C, D) considering the intended purpose of the devices. As an IVD manufacturer you should review the 7 classification rules given on Annex VIII of the IVDR and define the risk class of your device.

Compared to 98/79/EC IVD Directive (IVDD) the classification of the devices is one of the most important changes which manufacturers must comply during IVDR transition. The rigid classification system of IVDD now becomes a flexible IVDR Risk Classification system which enables room for new devices and technology developments.

In the good old days, most the IVD devices could be marketed with a self-declaration without a Notified Body intervention. Only List A, List B and self-test devices were required to go through a conformity assessment procedure via a Notified Body.

IVDR Risk Classification

The IVDR is now changing the game by increasing the Notified Body intervention during the conformity assessment procedures. Therefore, many manufacturers will go through a certification process for the first time. Considering the low number of available Notified Bodies and transition timelines, this seems to be real challenge for many mid-sized manufacturers.  

The MDCG 2020-16 Guidance brings clarification to the IVDR Risk Classification rules listed on Annex VIII. The guidance document includes rationale and examples (non-exhaustive) for each IVDR Risk Classification rule. Apart from the examples the initial paragraphs of the guidance document gives a very good summary about the principles of classification.

For details about IVDR and support to classify your IVD, you can consult our experts.

 
Share on linkedin
LinkedIn
Share on email
Email

Recent News

How can we help you?

If you need more information, we will be glad to have a chat
Connect With Us